Antimicrobial resistance in Helicobacter pylori isolates from children

S Rerksuppaphol1, W Hardikar, P D Midolo

  • 1Department of Paediatric Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Austin Hospital, Melbourne, Victoria, Australia.

Insights

Helicobacter pylori resistance to metronidazole is high in children, while clarithromycin resistance is moderate. Amoxycillin and tetracycline resistance were not observed, suggesting treatment modifications may be needed.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Antimicrobial resistance

Background:

  • Helicobacter pylori infection is common in children.
  • Treatment of H. pylori relies on effective antimicrobial agents.
  • Understanding antimicrobial resistance patterns is crucial for effective treatment.

Purpose of the Study:

  • To determine the antimicrobial resistance rates of H. pylori in pediatric patients.
  • To assess resistance to metronidazole, clarithromycin, amoxycillin, and tetracycline.

Main Methods:

  • Prospective collection of H. pylori isolates from children undergoing gastroscopy (July 1997-January 2000).
  • Susceptibility testing using E-test for four antimicrobial agents.
  • Retrospective collection of demographic, clinical, and treatment data.

Main Results:

  • High resistance rate to metronidazole (43.5%) and moderate resistance to clarithromycin (8.7%).
  • No resistance observed for amoxycillin or tetracycline.
  • No significant differences in patient characteristics or treatment outcomes between susceptible and resistant groups.

Conclusions:

  • Pediatric H. pylori resistance patterns to metronidazole and clarithromycin mirror adult data.
  • High resistance rates necessitate consideration of antimicrobial susceptibility testing for H. pylori management in children.
  • Treatment guidelines may require updates to ensure eradication efficacy.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...